Please Wait
Applying Filters...
USFDA APPLICATION NUMBER - 21937 / DOSAGE - TABLET;ORAL - 600MG;200MG;300MG
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| efavirenz(UNII: JE6H2O27P8) (efavirenz - UNII:JE6H2O27P8) | efavirenz | 600mg |
| emtricitabine(UNII: G70B4ETF4S) (emtricitabine - UNII:G70B4ETF4S) | emtricitabine | 200mg |
| tenofovir disoproxil fumarate(UNII: OTT9J7900I) (TENOFOVIR ANHYDROUS - UNII:W4HFE001U5) | tenofovir disoproxil fumarate | 300mg |
Inactive Ingredients
| Ingredient Name | A-S Medication Solutions | Avera McKennan Hospital | Cipla USA Inc. | Exelan Pharmaceuticals, Inc. | Lake Erie Medical DBA Quality Care Products LLC | REMEDYREPACK INC. | American Health Packaging |
|---|---|---|---|---|---|---|---|
| CELLULOSE, MICROCRYSTALLINE(OP1R32D61U) | |||||||
| CROSCARMELLOSE SODIUM(M28OL1HH48) | |||||||
| FERRIC OXIDE RED(1K09F3G675) | |||||||
| FERRIC OXIDE YELLOW(EX438O2MRT) | |||||||
| FERROSOFERRIC OXIDE(XM0M87F357) | |||||||
| HYDROXYPROPYL CELLULOSE (110000 WAMW)(5Y0974F5PW) | |||||||
| HYDROXYPROPYL CELLULOSE (1200000 MW)(RFW2ET671P) | |||||||
| HYDROXYPROPYL CELLULOSE (1600000 WAMW)(RFW2ET671P) | |||||||
| HYDROXYPROPYL CELLULOSE (TYPE H)(RFW2ET671P) | |||||||
| HYDROXYPROPYL CELLULOSE(RFW2ET671P) | |||||||
| HYPROMELLOSE, UNSPECIFIED(3NXW29V3WO) | |||||||
| ISOPROPYL ALCOHOL(ND2M416302) | |||||||
| LECITHIN, SOYBEAN(1DI56QDM62) | |||||||
| MAGNESIUM STEARATE(70097M6I30) | |||||||
| MICROCRYSTALLINE CELLULOSE(OP1R32D61U) | |||||||
| POLYETHYLENE GLYCOL 3350(G2M7P15E5P) | |||||||
| POLYVINYL ALCOHOL(532B59J990) | |||||||
| POLYVINYL ALCOHOL, UNSPECIFIED(532B59J990) | |||||||
| SODIUM LAURYL SULFATE(368GB5141J) | |||||||
| TALC(7SEV7J4R1U) | |||||||
| TITANIUM DIOXIDE(15FIX9V2JP) | |||||||
| XANTHAN GUM(TTV12P4NEE) |
